Abstract:<p>BACKGROUD & AIMS: Although SARS-CoV-2 infects gastrointestinal tissues, little is known about the roles of gut commensal microbes in susceptibility to and severity of infection. We investigated changes in fecal microbiomes of patients with SARS-CoV-2 infection during hospitalization and associations with severity and fecal shedding of virus.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">METHODS</h3><p>We performed shotgun metagenomic sequencing analyses of fecal samples from 15 patients with COVID-19 in Hong Kong, from February 5 through March 17, 2020. Fecal samples were collected 2 or 3 times per week from time of hospitalization until discharge; disease was categorized as mild (no radiographic evidence of pneumonia), moderate (pneumonia was present), severe (respiratory rate ≥30/min, or oxygen saturation ≤93% when breathing ambient air), or critical (respiratory failure requiring mechanical ventilation, shock, or organ failure requiring intensive care). We compared microbiome data with those from 6 subjects with community-acquired pneumonia and 15 healthy individuals (controls). We assessed gut microbiome profiles in association with disease severity and changes in fecal shedding of SARS-CoV-2.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">RESULTS</h3><p>Patients with COVID-19 had significant alterations in fecal microbiomes compared with controls, characterized by enrichment of opportunistic pathogens and depletion of beneficial commensals, at time of hospitalization and at all timepoints during hospitalization. Depleted symbionts and gut dysbiosis persisted even after clearance of SARS-CoV-2 (determined from throat swabs) and resolution of respiratory symptoms. The baseline abundance of <em>Coprobacillus</em>, <em>Clostridium ramosum</em>, and <em>Clostridium hathewayi</em> correlated with COVID-19 severity; there was an inverse correlation between abundance of <em>Faecalibacterium prausnitzii</em> (an anti-inflammatory bacterium) and disease severity. Over the course of hospitalization, <em>Bacteroides dorei</em>, <em>Bacteroides thetaiotaomicron</em>, <em>Bacteroides massiliensis</em>, and <em>Bacteroides ovatus,</em> which downregulate expression of ACE2 in murine gut, correlated inversely with SARS-CoV-2 load in fecal samples from patients.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">CONCLUSIONS</h3><p>In a pilot study of 15 patients with COVID-19, we found persistent alterations in the fecal microbiome during the time of hospitalization, compared with controls. Fecal microbiota alterations were associated with fecal levels of SARS-CoV-2 and COVID-19 severity. Strategies to alter the intestinal microbiota might reduce disease severity.</p>

Interim Proposal for Collecting and Handling of Microbiology Specimens from Patients with COVID‐19 in General Hospitals

Alterations of the Gut Microbiota in Patients with Coronavirus Disease 2019 or H1N1 Influenza.

Epidemiological, Clinical and Virological Characteristics of 74 Cases of Coronavirus-Infected Disease 2019 (COVID-19) with Gastrointestinal Symptoms

[Principles and Suggestions on Biosafety Protection of Biological Specimen Preservation During Prevalence of COVID-19].

Retrospective analysis of the clinical features of outpatients with novel coronavirus in areas outside Wuhan, China

Epidemiological, Clinical, Laboratorial and CT Imaging Features of Hospitalized Patients with Initially Negative Detection of SARS-CoV-2 in China

Characterization of Microbial Co-infections in the Respiratory Tract of hospitalized COVID-19 patients

Analysis of Lung Microbiome in COVID-19 Patients during Time of Hospitalization

Process and Specification for Collecting Nasal and Throat Swab Specimens from Hospitalized Patients with Novel Coronavirus Infection in the Department of Infectious Diseases

Detection of microorganisms in hospital air before and during the SARS-CoV-2 pandemic

Quality Management for Point-Of-Care Testing of Pathogen Nucleic Acids: Chinese Expert Consensus

Evaluation of Superinfection, Antimicrobial Usage, and Airway Microbiome with Metagenomic Sequencing in COVID-19 Patients: A Cohort Study in Shanghai

Stability issues of RT‐PCR testing of SARS‐CoV‐2 for hospitalized patients clinically diagnosed with COVID‐19

Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection

Patient safety recommendations and management in patients with COVID-19 pneumonia suspicion: a retrospective study

Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization

Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients

Environmental Assessment of SARS-CoV-2 for Internal Quality Management in a Clinical Laboratory

Microbiome characteristics description of COVID-19 patients based on bulk RNA-seq and scRNA-Seq data

Assessment of Microbiota in the Gut and Upper Respiratory Tract Associated with SARS-CoV-2 Infection

Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: An observational study